MeSH term
Frequency | Condition_Probility | Albumins/metabolism | 2 | 1.0 |
Albuminuria/*prevention & control | 2 | 2.0 |
Antihypertensive Agents/*therapeutic use | 2 | 0.0 |
Diabetes Mellitus, Type 2/complications/*drug therapy | 2 | 2.0 |
Humans | 17 | 0.0 |
Hypertension/complications/*drug therapy | 2 | 1.0 |
Indoles/*therapeutic use | 2 | 1.0 |
Renin-Angiotensin System/*drug effects | 2 | 1.0 |
Amino Acid Sequence | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Female | 4 | 0.0 |
Hepatoblastoma/*genetics | 2 | 11.0 |
Loss of Heterozygosity | 3 | 0.0 |
Male | 3 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Mutation | 4 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
*Repressor Proteins | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Signal Transduction | 3 | 0.0 |
*Trans-Activators | 6 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
*Zebrafish Proteins | 8 | 3.0 |
Animals | 4 | 0.0 |
Mice | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 5 | 0.0 |
Cell Line | 3 | 0.0 |
Cytoskeletal Proteins/*metabolism | 3 | 1.0 |
Genes, Reporter | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
*Signal Transduction | 3 | 0.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Chromosomes, Human, Pair 17/*genetics | 2 | 1.0 |
Cloning, Molecular | 3 | 0.0 |
Cytoskeletal Proteins/*genetics | 3 | 2.0 |
Proto-Oncogene Proteins/physiology | 2 | 1.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
Rats | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
DNA Methylation | 2 | 0.0 |
Aged | 2 | 0.0 |
Middle Aged | 2 | 0.0 |